I have watched the webinar again and have given some more thought to possible growth
- In Sept Qtr NGS did $US 760K in cash receipts AUD $1.21
- Steve indicated same is a expected/historically quiet qtr but achieved 2% uplift
So making a few assumptions/crystal balling - what might this Qtr look like - here are some thoughts (please feel free to critique - the more the better)
- NGS grow cash receipts by say a conservative 5% on current footprint from $760K to say $800K USD
- IHerb on boarded at start of Qtr - initial order of $10K already up to circa $30K - assume by end of Qtr that figure sits at say $40K USD
- New Walmart rollout completed end Sept so will operate for the full current Qtr
- 850 new stores
- Say they hit average of 1.25 units per store per week
- 1.25 * 850 = 1062 units per week by 12 weeks = 12,750 units
- Assume 12,000 units - shelf price is $22 USD so total sales would be circa $265K USD
- Not sure what our unit sale price is to Walmart but assume circa 50% - say $130K USD
So $800 + $40 + $130K = $970K USD which would be circa $1,540,000 AUD or annualised circa $6.15 million if repeated over a full year with no further growth or product lines being rolled out
Possibly I am smoking the whacky weed and drinking the cool aid but as I see it
- NGS in the next 6-10 weeks likely to be cash flow neutral or positive
- Second Walmart product now in shop/selling and when combined with moderate growth in existing footprint - NGS will by default lift sales compared to last qtr
- Steve confirmed targeting door expansion and other product lines in store over next 12 months (Iherb/CVS/Walmart/Amazon/Other) - so growth in doors/product lines will by default see further growth in sales
- Using logic above NGS might possibly report sales at end of this quarter circa $1.5 million AUD - annualised ciurca $6 million AUD
- Sits to a market cap of $2.7 million
- Forums
- ASX - By Stock
- Growth Possibilities
I have watched the webinar again and have given some more...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NGS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.169M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 4.0¢ | $30.55K | 758.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 123654 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 17484 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 123654 | 0.035 |
2 | 102092 | 0.031 |
1 | 350000 | 0.030 |
1 | 350000 | 0.025 |
1 | 25000 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 17484 | 1 |
0.048 | 20000 | 1 |
0.069 | 3000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NGS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online